A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered

- Jackson, Evangeline R., Persson, Mika L., Fish, Cameron J., Findlay, Izac J., Mueller, Sabine, Nazarian, Javad, Hulleman, Esther, van der Lugt, Jasper, Duchatel, Ryan J., Dun, Matthew D.

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models

- de la Nava, Daniel, Ausejo-Mauleon, Iker, Tallon-Cobos, Antonio Carlos, Hernandez-Osuna, Reyes, Marco-Sanz, Javier, Dhandapani, Laasya, Hervás-Corpión, Irati, Becher, Oren J., Nazarian, Javad, Mueller, Sabine, Phoenix, Timothy N., van der Lugt, Jasper, Laspidea, Virginia, Hernaez, Mikel, Guruceaga, E, Koschmann, C, Venneti, S, Allen, JE, Dun, Matthew D., Fueyo, J, Gomez-Manzano, C, Perez-Larraya, JG, Patiño-García, A, Gonzalez-Huarriz, Marisol, Labiano, S, Alonso, MM, Lacalle, Andrea, Casares, Noelia, Zalacain, Marta, Marrodan, Lucía, García-Moure, Marc, Ochoa, Maria C.

Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma

- Duchatel, Ryan J., Mannan, Abdul, Kearney, Padraic S., Smith, Nathan D., Hindley, Kate E., Cain, Jason E., André, Nicolas, La Madrid, Andres Morales, Nixon, Brett, De Iuliis, Geoffry N., Nazarian, Javad, Irish, Kathleen, Woldu, Ameha S., Alvaro, Frank, Eisenstat, DD, Beck, A, Vitanza, NA, Mueller, S, Morris, JC, Dun, Matthew D., Hawtrey, Tom, Hindley, Phoebe A., Douglas, Alicia M., Jackson, Evangeline R., Findlay, Izac J., Germon, Zacary P., Staudt, Dilana